Research and Development

The Research and Development team at Cytovia Therapeutics is dedicated to innovating and optimizing cancer immunotherapies, focusing on Natural Killer (NK) cell biology and precision medicine. Comprising experts in preclinical research and gene editing, the team conducts cutting-edge studies to develop novel therapeutic approaches aimed at preventing cancer relapse and metastasis. By leveraging advanced technologies and strategic partnerships, the team drives the discovery and development of targeted treatments for patients at various disease stages.